Literature DB >> 8042320

Relation between liver pathology and prognosis in patients with portal hypertension.

P A McCormick1, A K Burroughs.   

Abstract

The most common causes of variceal bleeding are cirrhosis, schistosomiasis, and extrahepatic portal venous obstruction. The prognosis for an individual patient depends on the severity of the bleeding episode and the underlying liver function. Liver function is determined to a large extent by the underlying liver pathology. Patients with noncirrhotic portal hypertension or cirrhosis with good liver function have good short- and long-term prognoses. In patients with established cirrhosis, the presence of alcoholic hepatitis, hepatocellular carcinoma, or portal venous thrombosis may adversely affect prognosis. In addition to affecting prognosis, the underlying pathology may also influence choice of treatment. This point is particularly true for treatments such as shunt surgery, liver transplantation, or transjugular intrahepatic shunts.

Entities:  

Mesh:

Year:  1994        PMID: 8042320     DOI: 10.1007/bf00294397

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  45 in total

1.  BLOOD AMMONIA DURING BLEEDING FROM ESOPHAGEAL VARICES IN PATIENTS WITH HEPATOSPLENIC SCHISTOSOMIASIS.

Authors:  K S WARREN; G REBOUCAS
Journal:  N Engl J Med       Date:  1964-10-29       Impact factor: 91.245

2.  Portal hypertension due to schistosomiasis mansoni.

Authors:  M R GARCIA-PALMIERI; R A MARCIAL-ROJAS
Journal:  Am J Med       Date:  1959-11       Impact factor: 4.965

3.  A comparative study of portal and bilharzial cirrhosis.

Authors:  H F RODRIGUEZ; M R GARCIA-PALMIERI; J V RIVERA; R RODRIGUEZ-MOLINA
Journal:  Gastroenterology       Date:  1955-08       Impact factor: 22.682

4.  Prophylactic sclerotherapy for esophageal varices in men with alcoholic liver disease. A randomized, single-blind, multicenter clinical trial.

Authors: 
Journal:  N Engl J Med       Date:  1991-06-20       Impact factor: 91.245

Review 5.  Non-cirrhotic portal fibrosis.

Authors:  J B Dilawari; S Ganguly; Y Chawla
Journal:  Indian J Gastroenterol       Date:  1992-01

6.  Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis.

Authors:  H Orrego; J E Blake; L M Blendis; A Medline
Journal:  Gastroenterology       Date:  1987-01       Impact factor: 22.682

7.  Operations for portal hypertension due to extrahepatic obstruction: results and 10 year follow up.

Authors:  G K Pande; V M Reddy; P Kar; P Sahni; M Berry; B N Tandon; S Nundy
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-31

8.  Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomized trial.

Authors:  D Lebrec; T Poynard; J P Capron; P Hillon; P Geoffroy; D Roulot; J C Chaput; B Rueff; J P Benhamou
Journal:  J Hepatol       Date:  1988-08       Impact factor: 25.083

Review 9.  Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules.

Authors:  I R Wanless
Journal:  Hepatology       Date:  1990-05       Impact factor: 17.425

10.  The aetiology, presentation and natural history of extra-hepatic portal venous obstruction.

Authors:  L J Webb; S Sherlock
Journal:  Q J Med       Date:  1979-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.